HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prolonged disease-free survival and overall survival with CVP alternating with fludarabine in advanced follicular lymphoma.

AuthorsWeiyun Z Ai, Holbrook E K Kohrt, John Timmerman, Jimmy Hwang, Frank J Hsu, Debra D Czerwinski, Behnaz Taidi, Ronald Levy
JournalAmerican journal of hematology (Am J Hematol) Vol. 86 Issue 6 Pg. 515-8 (Jun 2011) ISSN: 1096-8652 [Electronic] United States
PMID21538469 (Publication Type: Clinical Trial, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Vincristine
  • Cyclophosphamide
  • Vidarabine
  • fludarabine
  • Prednisone
Topics
  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols (administration & dosage, therapeutic use, toxicity)
  • Cyclophosphamide (administration & dosage)
  • Disease-Free Survival
  • Humans
  • Immunotherapy, Active
  • Lymphoma, Follicular (complications, drug therapy, mortality)
  • Middle Aged
  • Prednisone (administration & dosage)
  • Treatment Outcome
  • Vidarabine (administration & dosage, analogs & derivatives, toxicity)
  • Vincristine (administration & dosage)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: